Projects per year
Personal profile
Education
- 1994 Ph.D., Department of Biochemical Science Technology, National Taiwan University
- 1990 M.S., Department of Biochemical Science Technology, National Taiwan University
- 1989 M.D., Medical Laboratory Science and Biotechnology, Taipei Medical University
Experience
- 2018.12- Professor, Department of Medical Laboratory Science and Biotechnology, Taipei Medical University
- 2017- Vice Director, Research Center of Cancer Translational Medicine, Taipei Medical University
- 2015.02-2018.11 Professor, Graduate Institute of Medical Sciences, Taipei Medical University, Taiwan
- 2011.02-2015.01 Professor, Department of Medical Laboratory Science and Biotechnology, Taipei Medical University
Awards
- 2019 International Top Journal Publication Award, Taipei Medical University
Fingerprint Dive into the research topics where Yuan-Soon Ho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Breast Neoplasms
Medicine & Life Sciences
Apoptosis
Medicine & Life Sciences
Cells
Chemical Compounds
Neoplasms
Medicine & Life Sciences
Nicotine
Medicine & Life Sciences
Nicotinic Receptors
Medicine & Life Sciences
terbinafine
Medicine & Life Sciences
Hepatocellular Carcinoma
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2010 2020
乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估－α9尼古丁受體蛋白多形性變異致癌作用之機制探討(3/3)(相對補助)
8/1/19 → 7/1/20
Project: A - Government Institution › f - Other (Funded by Government)
組織胺甲基化轉換酵素(HNMT)輔助臨床醫師鑑別乳癌病患作為Herceptin療效評估之新穎分子標記(1/3)
8/1/19 → 7/1/20
Project: A - Government Institution › b - Ministry of Science and Technology
乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估-α9尼古丁受體蛋白多形性變異致癌作用之機制探討(3/3)
8/1/19 → 7/1/20
Project: A - Government Institution › b - Ministry of Science and Technology
乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估－α9尼古丁受體蛋白多形性變異致癌作用之機制探討(2/3)(相對補助)
8/1/18 → 7/31/20
Project: A - Government Institution › f - Other (Funded by Government)
乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估-α9尼古丁受體蛋白多形性變異致癌作用之機制探討(2/3)
8/1/18 → 7/1/19
Project: A - Government Institution › b - Ministry of Science and Technology
Research Output 1992 2019
A new histone deacetylase inhibitor enhances radiation sensitivity through the induction of misfolded protein aggregation and autophagy in triple-negative breast cancer
Chiu, H. W., Yeh, Y. L., Ho, S. Y., Wu, Y. H., Wang, B. J., Huang, W. J., Ho, Y. S., Wang, Y. J., Chen, L. C. & Tu, S. H., Nov 1 2019, In : Cancers. 11, 11, 1703.Research output: Contribution to journal › Article
Open Access
Triple Negative Breast Neoplasms
Histone Deacetylase Inhibitors
Radiation Tolerance
Autophagy
Proteins
3
Citations
(Scopus)
DNA primase polypeptide 1 (PRIM1) involves in estrogen-induced breast cancer formation through activation of the G2/M cell cycle checkpoint
Lee, W-H., Chen, L-C., Lee, C-J., Huang, C-C., Ho, Y-S., Yang, P-S., Ho, C-T., Chang, H-L., Lin, I-H., Chang, H-W., Liu, Y-R., Wu, C-H. & Tu, S-H., Feb 1 2019, In : International Journal of Cancer. 144, 3, p. 615-630 16 p.Research output: Contribution to journal › Article
DNA Primase
G2 Phase Cell Cycle Checkpoints
Estrogens
Breast Neoplasms
Peptides
Melatonin promotes neuroblastoma cell differentiation by activating hyaluronan synthase 3-induced mitophagy
Lee, W. J., Chen, L. C., Lin, J. H., Cheng, T. C., Kuo, C. C., Wu, C. H., Chang, H. W., Tu, S. H. & Ho, Y. S., Jan 1 2019, In : Cancer Medicine. 8, 10, p. 4821-4835 15 p.Research output: Contribution to journal › Article
Open Access
Mitochondrial Degradation
Melatonin
Neuroblastoma
Cell Differentiation
Spontaneous Remission
2
Citations
(Scopus)
Membrane protein-regulated networks across human cancers
Lin, C. Y., Lee, C. H., Chuang, Y. H., Lee, J. Y., Chiu, Y. Y., Wu Lee, Y. H., Jong, Y. J., Hwang, J. K., Huang, S. H., Chen, L. C., Wu, C. H., Tu, S. H., Ho, Y. S. & Yang, J. M., Dec 1 2019, In : Nature Communications. 10, 1, 3131.Research output: Contribution to journal › Article
Open Access
Membrane Proteins
cancer
membranes
proteins
Neoplasms
Proteasome 26s subunit, non-atpase 3 (Psmd3) regulates breast cancer by stabilizing her2 from degradation
Fararjeh, A. S., Chen, L. C., Ho, Y. S., Cheng, T. C., Liu, Y. R., Chang, H. L., Chang, H. W., Wu, C. H. & Tu, S. H., Apr 1 2019, In : Cancers. 11, 4, 527.Research output: Contribution to journal › Article
Open Access
Breast Neoplasms
human ERBB2 protein
ATP dependent 26S protease
Ubiquitination
Proteasome Endopeptidase Complex